Call us: + 31 (0)20 - 4350 580

Home > News

Combination immunotherapy: The latest revolution in cancer treatment

Combination immunotherapy: The latest revolution in cancer treatment
13 September 2018 - Romy Krikke BSc

An analysis of the clinical landscape The present focus in the treatment of cancer is immunotherapy, in particular immunotherapies that are trialed in a combination regimen. By combining immuno-oncology (IO) agents with oth...

Read more

ASCO 2018 recap - pembro the way to go?

ASCO 2018 recap - pembro the way to go?
11 June 2018 - Lindy Bosch MSc., Business Development

The 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) gathered over 32.000 oncology professionals from all over the world, highlighting the latest in cancer care treatments.

Read more

AACR2018 - Emerging trends in next generation immunotherapy

AACR2018 - Emerging trends in next generation immunotherapy
25 April 2018 - Nadina Grosios PhD MPH, Yuva Oz MSc.

Chicago hosted the 2018 annual meeting of the American Association for Cancer Research (AACR) in its cold spring days. As expected, enthusiasm centered on immunotherapy combination therapy and its challenges, and the possibilit...

Read more

The future of data management in clinical trials - ACDM 2018

The future of data management in clinical trials - ACDM 2018
11 April 2018 - José Matamoros Luna MSc., Clinical Data Manager

On March 13, Brussels was considered the capital of Data Management, hosting the annual conference of the Association for Clinical Data Management (ACDM). Since technologies and standards continue to evolve in the ever changing...

Read more

Power of targeted, personalized and combined therapies - TAT 2018

Power of targeted, personalized and combined therapies - TAT 2018
9 March 2018 - Yuva Oz MSc., Business Development

The home of Phase I oncology conference a.k.a. the Targeted Anticancer Therapies (TAT) conference took place this week in the beautiful city of Paris. The program is dedicated to early-phase development and translational resear...

Read more
Read more blog items